 | • レポートコード：QY2108PAL8896 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、153ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおける神経学的バイオマーカーの市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、神経学的バイオマーカーの種類別市場規模（プロテオミクス、ゲノミクス、画像、バイオインフォマティクス、その他）、用途別市場規模（診断、創薬、個別化医療、その他）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界の神経学的バイオマーカー市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界における神経学的バイオマーカーの種類別市場規模（2016年-2027年）：プロテオミクス、ゲノミクス、画像、バイオインフォマティクス、その他 ・世界における神経学的バイオマーカーの用途別市場規模（2016年-2027年）：診断、創薬、個別化医療、その他 ・神経学的バイオマーカーの中国市場分析 - 神経学的バイオマーカーの中国市場規模（2016年-2027年） - 中国における神経学的バイオマーカーの主要プレイヤー別市場シェア - 中国における神経学的バイオマーカーの種類別市場規模：プロテオミクス、ゲノミクス、画像、バイオインフォマティクス、その他 - 中国における神経学的バイオマーカーの用途別市場規模：診断、創薬、個別化医療、その他 ・神経学的バイオマーカーの北米市場（2016年-2027年） ・神経学的バイオマーカーのヨーロッパ市場（2016年-2027年） ・神経学的バイオマーカーのアジア太平洋市場（2016年-2027年） ・神経学的バイオマーカーの中南米市場（2016年-2027年） ・神経学的バイオマーカーの中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Thermo Fisher Scientific、Merck、Quest Diagnostics、Abbott、Roche、Illumina、Bio-Rad Laboratories、QIAGEN、Myriad RBM、Cisbio Bioassays、Athena Diagnostics、BGI、Wuxi APP、Aepodia、Proteome Sciences、Genewiz ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus.
Global Neurological Biomarkers key players include Thermo Fisher Scientific, Merck, Quest Diagnostics, Abbott, etc. Global top four manufacturers hold a share about 25%.
North America is the largest market, with a share over 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent.
In terms of product, Proteomics is the largest segment, with a share about 30%. And in terms of application, the largest application is Proteomics, followed by Drug Discovery, Personalized Medicine, etc.
Market Analysis and Insights: Global and China Neurological Biomarkers Market
This report focuses on global and China Neurological Biomarkers market.
In 2020, the global Neurological Biomarkers market size was US$ 6170 million and it is expected to reach US$ 13690 million by the end of 2027, with a CAGR of 12.0% during 2021-2027. In China the Neurological Biomarkers market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Neurological Biomarkers Scope and Market Size
Neurological Biomarkers market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Neurological Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Neurological Biomarkers market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Proteomics
Genomics
Imaging
Bioinformatics
Others
Segment by Application
Diagnostics
Drug Discovery
Personalized Medicine
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Thermo Fisher Scientific
Merck
Quest Diagnostics
Abbott
Roche
Illumina
Bio-Rad Laboratories
QIAGEN
Myriad RBM
Cisbio Bioassays
Athena Diagnostics
BGI
Wuxi APP
Aepodia
Proteome Sciences
Genewiz
1 Study Coverage
1.1 Neurological Biomarkers Product Introduction
1.2 Market by Type
1.2.1 Global Neurological Biomarkers Market Size Growth Rate by Type
1.2.2 Proteomics
1.2.3 Genomics
1.2.4 Imaging
1.2.5 Bioinformatics
1.2.6 Others
1.3 Market by Application
1.3.1 Global Neurological Biomarkers Market Size Growth Rate by Application
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Neurological Biomarkers Market Size, Estimates and Forecasts
2.1.1 Global Neurological Biomarkers Revenue 2016-2027
2.1.2 Global Neurological Biomarkers Sales 2016-2027
2.2 Global Neurological Biomarkers, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Neurological Biomarkers Historical Market Size by Region (2016-2021)
2.3.1 Global Neurological Biomarkers Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Neurological Biomarkers Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Neurological Biomarkers Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Neurological Biomarkers Sales Forecast by Region (2022-2027)
2.4.2 Global Neurological Biomarkers Revenue Forecast by Region (2022-2027)
3 Global Neurological Biomarkers Competitor Landscape by Players
3.1 Global Top Neurological Biomarkers Manufacturers by Sales
3.1.1 Global Neurological Biomarkers Sales by Manufacturer (2016-2021)
3.1.2 Global Neurological Biomarkers Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Neurological Biomarkers Manufacturers by Revenue
3.2.1 Key Neurological Biomarkers Manufacturers Covered: Ranking by Revenue
3.2.2 Global Neurological Biomarkers Revenue by Manufacturers (2016-2021)
3.2.3 Global Neurological Biomarkers Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Neurological Biomarkers Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Neurological Biomarkers Revenue in 2020
3.2.6 Global Neurological Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Neurological Biomarkers Price by Manufacturers
3.4 Global Neurological Biomarkers Manufacturing Base Distribution, Product Types
3.4.1 Neurological Biomarkers Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Neurological Biomarkers Product Type
3.4.3 Date of International Manufacturers Enter into Neurological Biomarkers Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Neurological Biomarkers Market Size by Type (2016-2021)
4.1.1 Global Neurological Biomarkers Sales by Type (2016-2021)
4.1.2 Global Neurological Biomarkers Revenue by Type (2016-2021)
4.1.3 Neurological Biomarkers Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Neurological Biomarkers Market Size Forecast by Type (2022-2027)
4.2.1 Global Neurological Biomarkers Sales Forecast by Type (2022-2027)
4.2.2 Global Neurological Biomarkers Revenue Forecast by Type (2022-2027)
4.2.3 Neurological Biomarkers Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Neurological Biomarkers Market Size by Application (2016-2021)
5.1.1 Global Neurological Biomarkers Sales by Application (2016-2021)
5.1.2 Global Neurological Biomarkers Revenue by Application (2016-2021)
5.1.3 Neurological Biomarkers Price by Application (2016-2021)
5.2 Neurological Biomarkers Market Size Forecast by Application (2022-2027)
5.2.1 Global Neurological Biomarkers Sales Forecast by Application (2022-2027)
5.2.2 Global Neurological Biomarkers Revenue Forecast by Application (2022-2027)
5.2.3 Global Neurological Biomarkers Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Neurological Biomarkers Market Size YoY Growth 2016-2027
6.1.1 China Neurological Biomarkers Sales YoY Growth 2016-2027
6.1.2 China Neurological Biomarkers Revenue YoY Growth 2016-2027
6.1.3 China Neurological Biomarkers Market Share in Global Market 2016-2027
6.2 China Neurological Biomarkers Market Size by Players (International and Local Players)
6.2.1 China Top Neurological Biomarkers Players by Sales (2016-2021)
6.2.2 China Top Neurological Biomarkers Players by Revenue (2016-2021)
6.3 China Neurological Biomarkers Historic Market Review by Type (2016-2021)
6.3.1 China Neurological Biomarkers Sales Market Share by Type (2016-2021)
6.3.2 China Neurological Biomarkers Revenue Market Share by Type (2016-2021)
6.3.3 China Neurological Biomarkers Price by Type (2016-2021)
6.4 China Neurological Biomarkers Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Neurological Biomarkers Sales Forecast by Type (2022-2027)
6.4.2 China Neurological Biomarkers Revenue Forecast by Type (2022-2027)
6.4.3 China Neurological Biomarkers Price Forecast by Type (2022-2027)
6.5 China Neurological Biomarkers Historic Market Review by Application (2016-2021)
6.5.1 China Neurological Biomarkers Sales Market Share by Application (2016-2021)
6.5.2 China Neurological Biomarkers Revenue Market Share by Application (2016-2021)
6.5.3 China Neurological Biomarkers Price by Application (2016-2021)
6.6 China Neurological Biomarkers Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Neurological Biomarkers Sales Forecast by Application (2022-2027)
6.6.2 China Neurological Biomarkers Revenue Forecast by Application (2022-2027)
6.6.3 China Neurological Biomarkers Price Forecast by Application (2022-2027)
7 North America
7.1 North America Neurological Biomarkers Market Size YoY Growth 2016-2027
7.2 North America Neurological Biomarkers Market Facts & Figures by Country
7.2.1 North America Neurological Biomarkers Sales by Country (2016-2021)
7.2.2 North America Neurological Biomarkers Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Neurological Biomarkers Market Size YoY Growth 2016-2027
8.2 Asia Pacific Neurological Biomarkers Market Facts & Figures by Region
8.2.1 Asia Pacific Neurological Biomarkers Sales by Region (2016-2021)
8.2.2 Asia Pacific Neurological Biomarkers Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Neurological Biomarkers Market Size YoY Growth 2016-2027
9.2 Europe Neurological Biomarkers Market Facts & Figures by Country
9.2.1 Europe Neurological Biomarkers Sales by Country (2016-2021)
9.2.2 Europe Neurological Biomarkers Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Neurological Biomarkers Market Size YoY Growth 2016-2027
10.2 Latin America Neurological Biomarkers Market Facts & Figures by Country
10.2.1 Latin America Neurological Biomarkers Sales by Country (2016-2021)
10.2.2 Latin America Neurological Biomarkers Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Neurological Biomarkers Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Neurological Biomarkers Market Facts & Figures by Country
11.2.1 Middle East and Africa Neurological Biomarkers Sales by Country (2016-2021)
11.2.2 Middle East and Africa Neurological Biomarkers Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Thermo Fisher Scientific
12.1.1 Thermo Fisher Scientific Corporation Information
12.1.2 Thermo Fisher Scientific Description and Business Overview
12.1.3 Thermo Fisher Scientific Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Thermo Fisher Scientific Neurological Biomarkers Products Offered
12.1.5 Thermo Fisher Scientific Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Description and Business Overview
12.2.3 Merck Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Merck Neurological Biomarkers Products Offered
12.2.5 Merck Recent Development
12.3 Quest Diagnostics
12.3.1 Quest Diagnostics Corporation Information
12.3.2 Quest Diagnostics Description and Business Overview
12.3.3 Quest Diagnostics Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Quest Diagnostics Neurological Biomarkers Products Offered
12.3.5 Quest Diagnostics Recent Development
12.4 Abbott
12.4.1 Abbott Corporation Information
12.4.2 Abbott Description and Business Overview
12.4.3 Abbott Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Abbott Neurological Biomarkers Products Offered
12.4.5 Abbott Recent Development
12.5 Roche
12.5.1 Roche Corporation Information
12.5.2 Roche Description and Business Overview
12.5.3 Roche Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Roche Neurological Biomarkers Products Offered
12.5.5 Roche Recent Development
12.6 Illumina
12.6.1 Illumina Corporation Information
12.6.2 Illumina Description and Business Overview
12.6.3 Illumina Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Illumina Neurological Biomarkers Products Offered
12.6.5 Illumina Recent Development
12.7 Bio-Rad Laboratories
12.7.1 Bio-Rad Laboratories Corporation Information
12.7.2 Bio-Rad Laboratories Description and Business Overview
12.7.3 Bio-Rad Laboratories Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Bio-Rad Laboratories Neurological Biomarkers Products Offered
12.7.5 Bio-Rad Laboratories Recent Development
12.8 QIAGEN
12.8.1 QIAGEN Corporation Information
12.8.2 QIAGEN Description and Business Overview
12.8.3 QIAGEN Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.8.4 QIAGEN Neurological Biomarkers Products Offered
12.8.5 QIAGEN Recent Development
12.9 Myriad RBM
12.9.1 Myriad RBM Corporation Information
12.9.2 Myriad RBM Description and Business Overview
12.9.3 Myriad RBM Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Myriad RBM Neurological Biomarkers Products Offered
12.9.5 Myriad RBM Recent Development
12.10 Cisbio Bioassays
12.10.1 Cisbio Bioassays Corporation Information
12.10.2 Cisbio Bioassays Description and Business Overview
12.10.3 Cisbio Bioassays Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Cisbio Bioassays Neurological Biomarkers Products Offered
12.10.5 Cisbio Bioassays Recent Development
12.11 Thermo Fisher Scientific
12.11.1 Thermo Fisher Scientific Corporation Information
12.11.2 Thermo Fisher Scientific Description and Business Overview
12.11.3 Thermo Fisher Scientific Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Thermo Fisher Scientific Neurological Biomarkers Products Offered
12.11.5 Thermo Fisher Scientific Recent Development
12.12 BGI
12.12.1 BGI Corporation Information
12.12.2 BGI Description and Business Overview
12.12.3 BGI Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.12.4 BGI Products Offered
12.12.5 BGI Recent Development
12.13 Wuxi APP
12.13.1 Wuxi APP Corporation Information
12.13.2 Wuxi APP Description and Business Overview
12.13.3 Wuxi APP Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Wuxi APP Products Offered
12.13.5 Wuxi APP Recent Development
12.14 Aepodia
12.14.1 Aepodia Corporation Information
12.14.2 Aepodia Description and Business Overview
12.14.3 Aepodia Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Aepodia Products Offered
12.14.5 Aepodia Recent Development
12.15 Proteome Sciences
12.15.1 Proteome Sciences Corporation Information
12.15.2 Proteome Sciences Description and Business Overview
12.15.3 Proteome Sciences Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Proteome Sciences Products Offered
12.15.5 Proteome Sciences Recent Development
12.16 Genewiz
12.16.1 Genewiz Corporation Information
12.16.2 Genewiz Description and Business Overview
12.16.3 Genewiz Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Genewiz Products Offered
12.16.5 Genewiz Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Neurological Biomarkers Industry Trends
13.2 Neurological Biomarkers Market Drivers
13.3 Neurological Biomarkers Market Challenges
13.4 Neurological Biomarkers Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Neurological Biomarkers Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Neurological Biomarkers Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Proteomics
Table 3. Major Manufacturers of Genomics
Table 4. Major Manufacturers of Imaging
Table 5. Major Manufacturers of Bioinformatics
Table 6. Major Manufacturers of Others
Table 7. Global Neurological Biomarkers Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 8. Global Neurological Biomarkers Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 9. Global Neurological Biomarkers Sales by Regions (2016-2021) & (K Units)
Table 10. Global Neurological Biomarkers Sales Market Share by Regions (2016-2021)
Table 11. Global Neurological Biomarkers Revenue by Regions (2016-2021) & (US$ Million)
Table 12. Global Neurological Biomarkers Sales Forecast by Region (2022-2027) & (K Units)
Table 13. Global Neurological Biomarkers Sales Market Share Forecast by Region (2022-2027)
Table 14. Global Neurological Biomarkers Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 15. Global Neurological Biomarkers Revenue Market Share Forecast by Region (2022-2027)
Table 16. Global Neurological Biomarkers Sales by Manufacturers (2016-2021) (K Units)
Table 17. Global Neurological Biomarkers Sales Share by Manufacturers (2016-2021)
Table 18. Ranking of Global Top Neurological Biomarkers Manufacturers by Revenue (US$ Million) in 2020
Table 19. Neurological Biomarkers Revenue by Manufacturers (2016-2021) (US$ Million)
Table 20. Neurological Biomarkers Revenue Share by Manufacturers (2016-2021)
Table 21. Global Neurological Biomarkers Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 22. Global Neurological Biomarkers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurological Biomarkers as of 2020)
Table 23. Key Manufacturers Neurological Biomarkers Price (2016-2021) (USD/Unit)
Table 24. Neurological Biomarkers Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Neurological Biomarkers Product Type
Table 26. Date of International Manufacturers Enter into Neurological Biomarkers Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Neurological Biomarkers Sales by Type (2016-2021) (K Units)
Table 29. Global Neurological Biomarkers Sales Share by Type (2016-2021)
Table 30. Global Neurological Biomarkers Revenue by Type (2016-2021) (US$ Million)
Table 31. Global Neurological Biomarkers Revenue Share by Type (2016-2021)
Table 32. Neurological Biomarkers Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 33. Global Neurological Biomarkers Sales Forecast by Type (2022-2027) & (K Units)
Table 34. Global Neurological Biomarkers Sales Market Share Forecast by Type (2022-2027)
Table 35. Global Neurological Biomarkers Revenue Forecast V (2022-2027) & (US$ Million)
Table 36. Global Neurological Biomarkers Revenue Market Share Forecast by Type (2022-2027)
Table 37. Global Neurological Biomarkers Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 38. Global Neurological Biomarkers Sales by Application (2016-2021) (K Units)
Table 39. Global Neurological Biomarkers Sales Share by Application (2016-2021)
Table 40. Global Neurological Biomarkers Revenue by Application (2016-2021) (US$ Million)
Table 41. Global Neurological Biomarkers Revenue Share by Application (2016-2021)
Table 42. Neurological Biomarkers Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 43. Global Neurological Biomarkers Sales Forecast by Application (2022-2027) & (K Units)
Table 44. Global Neurological Biomarkers Sales Market Share Forecast by Application (2022-2027)
Table 45. Global Neurological Biomarkers Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 46. Global Neurological Biomarkers Revenue Market Share Forecast by Application (2022-2027)
Table 47. Global Neurological Biomarkers Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 48. China Neurological Biomarkers Sales (K Units) of Key Companies (2016-2021)
Table 49. China Neurological Biomarkers Sales Share by Company (2016-2021)
Table 50. China Neurological Biomarkers Revenue (US$ Million) by Company (2016-2021)
Table 51. China Neurological Biomarkers Revenue Share by Company (2016-2021)
Table 52. China Neurological Biomarkers Sales (K Units) by Type (2016-2021)
Table 53. China Neurological Biomarkers Sales Share by Type (2016-2021)
Table 54. China Neurological Biomarkers Revenue (US$ Million) Market Share by Type (2016-2021)
Table 55. China Neurological Biomarkers Price (USD/Unit) by Type (2016-2021)
Table 56. China Neurological Biomarkers Sales (K Units) by Type (2022-2027)
Table 57. China Neurological Biomarkers Sales Share by Type (2022-2027)
Table 58. China Neurological Biomarkers Revenue (US$ Million) Market Share by Type (2022-2027)
Table 59. China Neurological Biomarkers Revenue Share by Type (2022-2027)
Table 60. China Neurological Biomarkers Price (USD/Unit) by Type (2022-2027)
Table 61. China Neurological Biomarkers Sales (K Units) by Application (2016-2021)
Table 62. China Neurological Biomarkers Sales Share by Application (2016-2021)
Table 63. China Neurological Biomarkers Revenue (US$ Million) Market Share by Application (2016-2021)
Table 64. China Neurological Biomarkers Price (USD/Unit) by Application (2016-2021)
Table 65. China Neurological Biomarkers Sales (K Units) by Application (2022-2027)
Table 66. China Neurological Biomarkers Sales Share by Application (2022-2027)
Table 67. China Neurological Biomarkers Revenue (US$ Million) Market Share by Application (2022-2027)
Table 68. China Neurological Biomarkers Revenue Share by Application (2022-2027)
Table 69. China Neurological Biomarkers Price (USD/Unit) by Application (2022-2027)
Table 70. North America Neurological Biomarkers Sales by Country (2016-2021) & (K Units)
Table 71. North America Neurological Biomarkers Sales Market Share by Country (2016-2021)
Table 72. North America Neurological Biomarkers Revenue by Country (2016-2021) & (US$ Million)
Table 73. North America Neurological Biomarkers Revenue Market Share by Country (2016-2021)
Table 74. Asia Pacific Neurological Biomarkers Sales by Region (2016-2021) & (K Units)
Table 75. Asia Pacific Neurological Biomarkers Sales Market Share by Region (2016-2021)
Table 76. Asia Pacific Neurological Biomarkers Revenue by Region (2016-2021) & (US$ Million)
Table 77. Asia Pacific Neurological Biomarkers Revenue Market Share by Region (2016-2021)
Table 78. Europe Neurological Biomarkers Sales by Country (2016-2021) & (K Units)
Table 79. Europe Neurological Biomarkers Sales Market Share by Country (2016-2021)
Table 80. Europe Neurological Biomarkers Revenue by Country (2016-2021) & (US$ Million)
Table 81. Europe Neurological Biomarkers Revenue Market Share by Country (2016-2021)
Table 82. Latin America Neurological Biomarkers Sales by Country (2016-2021) & (K Units)
Table 83. Latin America Neurological Biomarkers Sales Market Share by Country (2016-2021)
Table 84. Latin Americaa Neurological Biomarkers Revenue by Country (2016-2021) & (US$ Million)
Table 85. Latin America Neurological Biomarkers Revenue Market Share by Country (2016-2021)
Table 86. Middle East and Africa Neurological Biomarkers Sales by Country (2016-2021) & (K Units)
Table 87. Middle East and Africa Neurological Biomarkers Sales Market Share by Country (2016-2021)
Table 88. Middle East and Africa Neurological Biomarkers Revenue by Country (2016-2021) & (US$ Million)
Table 89. Middle East and Africa Neurological Biomarkers Revenue Market Share by Country (2016-2021)
Table 90. Thermo Fisher Scientific Corporation Information
Table 91. Thermo Fisher Scientific Description and Business Overview
Table 92. Thermo Fisher Scientific Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 93. Thermo Fisher Scientific Neurological Biomarkers Product
Table 94. Thermo Fisher Scientific Recent Development
Table 95. Merck Corporation Information
Table 96. Merck Description and Business Overview
Table 97. Merck Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 98. Merck Product
Table 99. Merck Recent Development
Table 100. Quest Diagnostics Corporation Information
Table 101. Quest Diagnostics Description and Business Overview
Table 102. Quest Diagnostics Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 103. Quest Diagnostics Product
Table 104. Quest Diagnostics Recent Development
Table 105. Abbott Corporation Information
Table 106. Abbott Description and Business Overview
Table 107. Abbott Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 108. Abbott Product
Table 109. Abbott Recent Development
Table 110. Roche Corporation Information
Table 111. Roche Description and Business Overview
Table 112. Roche Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Roche Product
Table 114. Roche Recent Development
Table 115. Illumina Corporation Information
Table 116. Illumina Description and Business Overview
Table 117. Illumina Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Illumina Product
Table 119. Illumina Recent Development
Table 120. Bio-Rad Laboratories Corporation Information
Table 121. Bio-Rad Laboratories Description and Business Overview
Table 122. Bio-Rad Laboratories Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Bio-Rad Laboratories Product
Table 124. Bio-Rad Laboratories Recent Development
Table 125. QIAGEN Corporation Information
Table 126. QIAGEN Description and Business Overview
Table 127. QIAGEN Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. QIAGEN Product
Table 129. QIAGEN Recent Development
Table 130. Myriad RBM Corporation Information
Table 131. Myriad RBM Description and Business Overview
Table 132. Myriad RBM Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Myriad RBM Product
Table 134. Myriad RBM Recent Development
Table 135. Cisbio Bioassays Corporation Information
Table 136. Cisbio Bioassays Description and Business Overview
Table 137. Cisbio Bioassays Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Cisbio Bioassays Product
Table 139. Cisbio Bioassays Recent Development
Table 140. Athena Diagnostics Corporation Information
Table 141. Athena Diagnostics Description and Business Overview
Table 142. Athena Diagnostics Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Athena Diagnostics Product
Table 144. Athena Diagnostics Recent Development
Table 145. BGI Corporation Information
Table 146. BGI Description and Business Overview
Table 147. BGI Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 148. BGI Product
Table 149. BGI Recent Development
Table 150. Wuxi APP Corporation Information
Table 151. Wuxi APP Description and Business Overview
Table 152. Wuxi APP Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 153. Wuxi APP Product
Table 154. Wuxi APP Recent Development
Table 155. Aepodia Corporation Information
Table 156. Aepodia Description and Business Overview
Table 157. Aepodia Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Aepodia Product
Table 159. Aepodia Recent Development
Table 160. Proteome Sciences Corporation Information
Table 161. Proteome Sciences Description and Business Overview
Table 162. Proteome Sciences Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Proteome Sciences Product
Table 164. Proteome Sciences Recent Development
Table 165. Genewiz Corporation Information
Table 166. Genewiz Description and Business Overview
Table 167. Genewiz Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 168. Genewiz Product
Table 169. Genewiz Recent Development
Table 170. Neurological Biomarkers Market Trends
Table 171. Neurological Biomarkers Market Drivers
Table 172. Neurological Biomarkers Market Challenges
Table 173. Neurological Biomarkers Market Restraints
Table 174. Neurological Biomarkers Customers List
Table 175. Neurological Biomarkers Distributors List
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Neurological Biomarkers Product Picture
Figure 2. Global Neurological Biomarkers Sales Market Share by Type in 2020 & 2027
Figure 3. Proteomics Product Picture
Figure 4. Genomics Product Picture
Figure 5. Imaging Product Picture
Figure 6. Bioinformatics Product Picture
Figure 7. Others Product Picture
Figure 8. Global Neurological Biomarkers Sales Market Share by Application in 2020 & 2027
Figure 9. Diagnostics
Figure 10. Drug Discovery
Figure 11. Personalized Medicine
Figure 12. Others
Figure 13. Neurological Biomarkers Report Years Considered
Figure 14. Global Neurological Biomarkers Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Neurological Biomarkers Market Size 2016-2027 (US$ Million)
Figure 16. Global Neurological Biomarkers Sales 2016-2027 (K Units)
Figure 17. Global Neurological Biomarkers Market Size Market Share by Region: 2021 Versus 2027
Figure 18. Global Neurological Biomarkers Sales Market Share by Region (2016-2021)
Figure 19. Global Neurological Biomarkers Sales Market Share by Region in 2020
Figure 20. Global Neurological Biomarkers Revenue Market Share by Region (2016-2021)
Figure 21. Global Neurological Biomarkers Revenue Market Share by Region in 2020
Figure 22. Global Neurological Biomarkers Sales Share by Manufacturer in 2020
Figure 23. The Top 10 and 5 Players Market Share by Neurological Biomarkers Revenue in 2020
Figure 24. Neurological Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 25. Global Neurological Biomarkers Sales Market Share by Type (2016-2021)
Figure 26. Global Neurological Biomarkers Sales Market Share by Type in 2020
Figure 27. Global Neurological Biomarkers Revenue Market Share by Type (2016-2021)
Figure 28. Global Neurological Biomarkers Revenue Market Share by Type in 2020
Figure 29. Global Neurological Biomarkers Sales Market Share by Application (2016-2021)
Figure 30. Global Neurological Biomarkers Sales Market Share by Application in 2020
Figure 31. Global Neurological Biomarkers Revenue Market Share by Application (2016-2021)
Figure 32. Global Neurological Biomarkers Revenue Market Share by Application in 2020
Figure 33. China Neurological Biomarkers Sales Growth Rate 2016-2027 (K Units)
Figure 34. China Neurological Biomarkers Revenue Growth Rate 2016-2027 (US$ Million)
Figure 35. China Neurological Biomarkers Market Share in Global Market 2016-2027
Figure 36. China 5 and 10 Largest Neurological Biomarkers Players Market Share by Revenue in Neurological Biomarkers in 2020
Figure 37. China Neurological Biomarkers Revenue Share by Type (2016-2021)
Figure 38. China Neurological Biomarkers Revenue Growth Rate by Type in 2016 & 2020
Figure 39. China Neurological Biomarkers Revenue Share by Application (2016-2021)
Figure 40. China Neurological Biomarkers Revenue Growth Rate by Application in 2016 & 2020
Figure 41. North America Neurological Biomarkers Sales Growth Rate 2016-2021 (K Units)
Figure 42. North America Neurological Biomarkers Revenue Growth Rate 2016-2021 (US$ Million)
Figure 43. North America Neurological Biomarkers Sales Market Share by Country in 2020
Figure 44. North America Neurological Biomarkers Revenue Market Share by Country in 2020
Figure 45. U.S. Neurological Biomarkers Sales Growth Rate (2016-2021) (K Units)
Figure 46. U.S. Neurological Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Canada Neurological Biomarkers Sales Growth Rate (2016-2021) (K Units)
Figure 48. Canada Neurological Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Europe Neurological Biomarkers Sales Growth Rate 2016-2021 (K Units)
Figure 50. Europe Neurological Biomarkers Revenue Growth Rate 2016-2021 (US$ Million)
Figure 51. Europe Neurological Biomarkers Sales Market Share by Country in 2020
Figure 52. Europe Neurological Biomarkers Revenue Market Share by Country in 2020
Figure 53. Germany Neurological Biomarkers Sales Growth Rate (2016-2021) (K Units)
Figure 54. Germany Neurological Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. France Neurological Biomarkers Sales Growth Rate (2016-2021) (K Units)
Figure 56. France Neurological Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. U.K. Neurological Biomarkers Sales Growth Rate (2016-2021) (K Units)
Figure 58. U.K. Neurological Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Italy Neurological Biomarkers Sales Growth Rate (2016-2021) (K Units)
Figure 60. Italy Neurological Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Russia Neurological Biomarkers Sales Growth Rate (2016-2021) (K Units)
Figure 62. Russia Neurological Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 63. Asia Pacific Neurological Biomarkers Sales Growth Rate 2016-2021 (K Units)
Figure 64. Asia Pacific Neurological Biomarkers Revenue Growth Rate 2016-2021 (US$ Million)
Figure 65. Asia Pacific Neurological Biomarkers Sales Market Share by Region in 2020
Figure 66. Asia Pacific Neurological Biomarkers Revenue Market Share by Region in 2020
Figure 67. China Neurological Biomarkers Sales Growth Rate (2016-2021) (K Units)
Figure 68. China Neurological Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. Japan Neurological Biomarkers Sales Growth Rate (2016-2021) (K Units)
Figure 70. Japan Neurological Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. South Korea Neurological Biomarkers Sales Growth Rate (2016-2021) (K Units)
Figure 72. South Korea Neurological Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. India Neurological Biomarkers Sales Growth Rate (2016-2021) (K Units)
Figure 74. India Neurological Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Australia Neurological Biomarkers Sales Growth Rate (2016-2021) (K Units)
Figure 76. Australia Neurological Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Taiwan Neurological Biomarkers Sales Growth Rate (2016-2021) (K Units)
Figure 78. Taiwan Neurological Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Indonesia Neurological Biomarkers Sales Growth Rate (2016-2021) (K Units)
Figure 80. Indonesia Neurological Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Thailand Neurological Biomarkers Sales Growth Rate (2016-2021) (K Units)
Figure 82. Thailand Neurological Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Malaysia Neurological Biomarkers Sales Growth Rate (2016-2021) (K Units)
Figure 84. Malaysia Neurological Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Philippines Neurological Biomarkers Sales Growth Rate (2016-2021) (K Units)
Figure 86. Philippines Neurological Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Vietnam Neurological Biomarkers Sales Growth Rate (2016-2021) (K Units)
Figure 88. Vietnam Neurological Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 89. Latin America Neurological Biomarkers Sales Growth Rate 2016-2021 (K Units)
Figure 90. Latin America Neurological Biomarkers Revenue Growth Rate 2016-2021 (US$ Million)
Figure 91. Latin America Neurological Biomarkers Sales Market Share by Country in 2020
Figure 92. Latin America Neurological Biomarkers Revenue Market Share by Country in 2020
Figure 93. Mexico Neurological Biomarkers Sales Growth Rate (2016-2021) (K Units)
Figure 94. Mexico Neurological Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Brazil Neurological Biomarkers Sales Growth Rate (2016-2021) (K Units)
Figure 96. Brazil Neurological Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Argentina Neurological Biomarkers Sales Growth Rate (2016-2021) (K Units)
Figure 98. Argentina Neurological Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 99. Middle East and Africa Neurological Biomarkers Sales Growth Rate 2016-2021 (K Units)
Figure 100. Middle East and Africa Neurological Biomarkers Revenue Growth Rate 2016-2021 (US$ Million)
Figure 101. Middle East and Africa Neurological Biomarkers Sales Market Share by Country in 2020
Figure 102. Middle East and Africa Neurological Biomarkers Revenue Market Share by Country in 2020
Figure 103. Turkey Neurological Biomarkers Sales Growth Rate (2016-2021) (K Units)
Figure 104. Turkey Neurological Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. Saudi Arabia Neurological Biomarkers Sales Growth Rate (2016-2021) (K Units)
Figure 106. Saudi Arabia Neurological Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 107. U.A.E Neurological Biomarkers Sales Growth Rate (2016-2021) (K Units)
Figure 108. U.A.E Neurological Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 109. Neurological Biomarkers Value Chain
Figure 110. Channels of Distribution
Figure 111. Distributors Profiles
Figure 112. Bottom-up and Top-down Approaches for This Report
Figure 113. Data Triangulation
Figure 114. Key Executives Interviewed
治療・診断用バイオマーカー商品化の世界市場 2020年 Market Overview The Commercializing Biomarkers in Therapeutic and Diagnostic Applications market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and …- コンピュテーショナル創薬の世界市場 2020年 Market Overview The Computational Drug Discovery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- 個別化医療/エピゲノミクスの世界市場 2020年 Market Overview The global Personalized Medicine and Epigenomics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Persona…
- 外傷性脳損傷（TBI）治療の世界市場 2020年 Market Overview The global Traumatic Brain Injuries Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.8% in the forecast period of 2020 to 2025 and will expected to reach USD 2424 million by 2025, from USD 2173.2 million in 2019. The Tra…
- 創薬におけるアウトソーシングの世界市場 2020年 Market Overview The global Outsourcing in Drug Discovery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Outsourcing in …